诺和诺德Novo Nordisk (NVO) 2023年年度报告「NYSE」.pdf

1、Annual Report 2023Novo Nordisk A/S Novo Alle 1,2880 Bagsvrd,Denmark CVR no.24256790 Juan Pablo Villaseor lives with obesity and cardiovascular disease.Until recently,Juan struggled with stigma and often blamed himself for not being able to lose weight.Today,he exercises regularly and spends quality

2、time with his son.Watch Juans full story hereParticipants at the Future Scientists Summer Camp,organised by Novo Nordisk and the LIFE Foundation to celebrate Novo Nordisks 100-year anniversary in 2023.3 Introducing Novo Nordisk4 Letter from the Chair and the CEO6 Novo Nordisk at a glance7 Our value

3、creation8 Performance highlights10 Strategic Aspirations11 Purpose and sustainability23 Innovation and therapeutic focus30 Commercial execution34 Financials40 Risks41 Risk management42 Key operational risks43 Management44 Board of Directors47 Executive Management50 Consolidated financial statements5

4、0 Income statement and Statement of comprehensive income51 Cash flow statement52 Balance sheet53 Equity statement54 Notes to the consolidated financial statements86 Consolidated ESG statement86 Statement of ESG performance87 Notes to the consolidated ESG statement95 Statements and Auditors Reports95

5、 Statement by the Board of Directors and Executive Management96 Independent Auditors Report98 Independent Assurance Report on the ESG statement99 Additional information100 More information101 Product overview102 ESG initiatives104 Sustainability frameworks and performanceManagement reviewConsolidate

6、d statements and additional informationNovo Nordisk Annual Report 20232Introducing Novo NordiskStrategic AspirationsRisksManagementConsolidated statementsAdditional information Quresha Nur comes from a village near Mombasa,Kenya.She was diagnosed with type 1 diabetes aged seven and was discriminated